5Sun Y, Lin X, Chen HM, etal. Administration of agonistic anti 4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis[J]. J Immunol, 2002, 68: 1457-1465.
6Seo SK, Choi JH , Kim YH, et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis[J]. Nat Med, 2004, 10: 1088-1094.
7Jung HW, La SJ, Kim JY, etal. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases[J]. Exp Mol Med, 2003,35 : 501- 508.
8Langstein J, Michel J, Schwarz H, et al. CD137 induces proliferation and endomitosis in monocytes[J]. Blood, 1999, 94:3161-3168.
9Langstein J, Schwarz H. Identification of CD137 as a potent monocyte survival factor[J].J Leukoc Biol, 1999,65:829-833.
10Sabel MS, Conway TF, Chen FA, et al. Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte mediated suppression of tumor xenografts in severe combined immunodeficient mice[J]. J Immunother, 2000,23:362-368.
